Koji Fukata1, Norihiro Yuasa2, Eiji Takeuchi2, Hideo Miyake2, Hidemasa Nagai2, Yuichiro Yoshioka2, Kanji Miyata2. 1. Department of Gastrointestinal Surgery, Japanese Red Cross Nagoya First Hospital, Nakamura-ku Michishita 3-35, Nagoya, Aichi, Japan. f.k.t.koji@gmail.com. 2. Department of Gastrointestinal Surgery, Japanese Red Cross Nagoya First Hospital, Nakamura-ku Michishita 3-35, Nagoya, Aichi, Japan.
Abstract
PURPOSE: A growing body of evidence suggests that right-sided colorectal cancer (RCRC) differs from left-sided colorectal cancer (LCRC) in certain clinicopathological features. Therefore, we investigated the difference between RCRC and LCRC in a series of 899 patients. METHODS: We reviewed data retrospectively, from 899 patients who underwent R0-resection for stage II and III CRC and compared the clinicopathological factors between patients with RCRC and LCRC. RESULTS: The patients with RCRC tended to be older, more likely female, with a larger tumor, higher pathological T stage, and a greater proportion of their tumors were poorly differentiated adenocarcinoma, mucinous adenocarcinoma, or signet ring cell carcinoma than the patients with LCRC,. Recurrence-free survival (RFS) of the patients with RCRC tended to be higher than that of the patients with LCRC and was significantly better among patients with stage II cancer. The overall survival (OS) was similar for patients with RCRC and LCRC, irrespective of cancer stage. CONCLUSION: Compared with the patients with LCRC, those with RCRC had several oncologically unfavorable factors, with better RFS in stage II and similar OS in stages II and III. These results suggest that the biological aggressiveness of RCRC is lower than that of LCRC in stage II; however, it can increase after relapse.
PURPOSE: A growing body of evidence suggests that right-sided colorectal cancer (RCRC) differs from left-sided colorectal cancer (LCRC) in certain clinicopathological features. Therefore, we investigated the difference between RCRC and LCRC in a series of 899 patients. METHODS: We reviewed data retrospectively, from 899 patients who underwent R0-resection for stage II and III CRC and compared the clinicopathological factors between patients with RCRC and LCRC. RESULTS: The patients with RCRC tended to be older, more likely female, with a larger tumor, higher pathological T stage, and a greater proportion of their tumors were poorly differentiated adenocarcinoma, mucinous adenocarcinoma, or signet ring cell carcinoma than the patients with LCRC,. Recurrence-free survival (RFS) of the patients with RCRC tended to be higher than that of the patients with LCRC and was significantly better among patients with stage II cancer. The overall survival (OS) was similar for patients with RCRC and LCRC, irrespective of cancer stage. CONCLUSION: Compared with the patients with LCRC, those with RCRC had several oncologically unfavorable factors, with better RFS in stage II and similar OS in stages II and III. These results suggest that the biological aggressiveness of RCRC is lower than that of LCRC in stage II; however, it can increase after relapse.
Authors: K Birkenkamp-Demtroder; S H Olesen; F B Sørensen; S Laurberg; P Laiho; L A Aaltonen; T F Orntoft Journal: Gut Date: 2005-03 Impact factor: 23.059
Authors: Fotios Loupakis; Dongyun Yang; Linda Yau; Shibao Feng; Chiara Cremolini; Wu Zhang; Martin K H Maus; Carlotta Antoniotti; Christiane Langer; Stefan J Scherer; Thomas Müller; Herbert I Hurwitz; Leonard Saltz; Alfredo Falcone; Heinz-Josef Lenz Journal: J Natl Cancer Inst Date: 2015-02-24 Impact factor: 13.506
Authors: E Missiaglia; B Jacobs; G D'Ario; A F Di Narzo; C Soneson; E Budinska; V Popovici; L Vecchione; S Gerster; P Yan; A D Roth; D Klingbiel; F T Bosman; M Delorenzi; S Tejpar Journal: Ann Oncol Date: 2014-07-23 Impact factor: 32.976
Authors: Sara Sakjah; Anna Sofie Friis Olsen; Anders Kierkegaard Gundestrup; Pernille Wolder Born; Birgitte Bols; Peter Ingeholm; Jakob Kleif; Claus Anders Bertelsen Journal: Colorectal Dis Date: 2022-04-08 Impact factor: 3.917